Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population
- 1 August 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 44 (2), 341-351
- https://doi.org/10.1002/hep.21252
Abstract
We conducted an anonymous cross‐sectional seroprevalence study of a population with a low frequency of injection drug use to determine whether persons with a history of cosmetic procedures, such as tattooing and body piercing, or intranasal drug use were at increased risk for hepatitis C virus (HCV) or hepatitis B virus (HBV) infection. Students 18 years and older from eight college campuses in Houston, Texas, were invited to participate in the study. Of the 7,960 who completed a self‐administered questionnaire and provided a blood sample, 5,282 U.S.‐ or Canadian‐born participants were analyzed. Their median age was 21, 62% were female, 42% were white, 26% black, 22% Hispanic, and 10% Asian or other. Two percent reported injection drug use, 13.7% intranasal drug use, 21.2% body piercings, and 25.2% tattoos. The overall prevalence of HCV infection was 0.9% and of HBV infection was 5.2%. Higher HCV prevalence was independently associated with increasing age (odds ratio [OR] per year = 1.11; 95% confidence interval [CI] = 1.08‐1.14), history of injection drug use (OR = 18.24; 95% CI = 7.74‐42.92), blood transfusion before 1991 (OR = 3.21; 95% CI = 1.02‐10.12), and incarceration (OR = 3.48; 95% CI = 1.45‐8.37). Among 5,066 students who denied injecting drugs, HCV prevalence was 0.8% in those who reported intranasal drug use and 0.6% each in those who reported tattoos and those who reported body piercing. Increased HBV prevalence was associated with high‐risk sexual behaviors and black or Asian race. In conclusion, there was no increased risk for HCV or HBV infection in low‐risk adults based solely on history of cosmetic procedures or snorting drugs. However, proper infection control practices for cosmetic procedures should be followed, illegal drug use discouraged, and hepatitis B vaccination provided to adolescents and sexually active adults. (HEPATOLOGY 2006;44:341–351.)This publication has 21 references indexed in Scilit:
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Evaluation of Screening Criteria to Identify Persons With Hepatitis C Virus Infection Among Sexually Transmitted Disease Clinic ClientsSexually Transmitted Diseases, 2003
- Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital.Digestive Diseases and Sciences, 2003
- Prevalence and risk factors for hepatitis C virus infection at an Urban veterans administration medical centerHepatology, 2001
- Commercial Tattooing as a Potentially Important Source of Hepatitis C InfectionMedicine, 2001
- Risk factors for hepatitis C virus infection in United States blood donorsHepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994The New England Journal of Medicine, 1999
- A Case-Control Study of Risk Factors for Sporadic Hepatitis C Virus Infection in The Southwestern United StatesThe American Journal of Gastroenterology, 1999
- Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus InfectionThe New England Journal of Medicine, 1996
- Sporadic Non-A, Non-B Hepatitis: Frequency and Epidemiology in an Urban U.S. PopulationThe Journal of Infectious Diseases, 1982